As of Sep 30
| +0.03 / +0.97%|
The 8 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 7.00, with a high estimate of 9.50 and a low estimate of 5.10. The median estimate represents a +123.64% increase from the last price of 3.13.
The current consensus among 8 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.